List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 107 studies with search of: Abacavir/Lamivudine OR Epzicom[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Unknown † Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir and Abacavir/Lamivudine
2 Completed
Has Results 		Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
Condition: HIV Infection
Interventions: Drug: emtricitabine/tenofovir;   Drug: abacavir/lamivudine
3 Unknown † A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
Condition: HIV
Interventions: Drug: fos-amprenavir calcium, ritonavir;   Drug: abacavir/lamivudine as Epzicom
4 Recruiting Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
5 Completed Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Abacavir/Lamivudine;   Drug: Lersivirine
6 Active, not recruiting A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Reyataz + Norvir + Truvada;   Drug: Reyataz + Epzicom
7 Completed A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
Condition: Human Immunodeficiency Virus Infections
Interventions: Drug: Lexiva + Norvir + Epzicom;   Drug: Sustiva + Epzicom
8 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
9 Completed Pharmacokinetic Study Of EPZICOM Tablet
Condition: HIV Infection
Intervention: Drug: Lamivudine / Abacavir Sulfate
10 Active, not recruiting A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)
Conditions: Sexually Transmitted Diseases;   HIV (Human Immunodeficiency Virus)-Infected Adults;   Infection, Human Immunodeficiency Virus I;   Acquired Immunodeficiency Syndrome;   HIV Infection;   Infection, Human Immunodeficiency Virus;   Antiretroviral Therapy (ART)-naïve Adults
Interventions: Drug: GSK1349572;   Drug: Atripla
11 Active, not recruiting Artery Elasticity After Switch From Epzicom to Truvada
Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil
12 Completed A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: abacavir/lamivudine;   Drug: abacavir;   Drug: lamivudine
13 Completed
Has Results 		Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
Condition: HIV Infections
Interventions: Drug: Abacavir/Lamivudine;   Drug: Atazanavir;   Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Ritonavir;   Drug: Abacavir/Lamivudine placebo;   Drug: Emtricitabine/Tenofovir disoproxil fumarate placebo
14 Completed Safety and Efficacy Study of Switching From Epzicom to Truvada
Condition: HIV Infection
Interventions: Drug: tenofovir/emtricitabine;   Drug: Abacavir(ABC)/Lamivudine(3TC)
15 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
16 Not yet recruiting Study of Options for Second-Line Effective Combination Therapy (SELECT)
Condition: HIV-1 Infection
Interventions: Drug: Lopinavir/ritonavir;   Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Abacavir/lamivudine/zidovudine;   Drug: Abacavir/lamivudine;   Drug: Lamivudine/zidovudine;   Drug: Abacavir;   Drug: Zidovudine;   Drug: Lamivudine
17 Recruiting Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir; Abacavir/Lamivudine
18 Completed A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy
Condition: HIV Infection
Interventions: Drug: efavirenz;   Drug: tenofovir;   Drug: abacavir/lamivudine
19 Completed New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects
Conditions: Human Immunodeficiency Virus I Infection;   HIV Infection
Interventions: Drug: abacavir/lamivudine;   Drug: abacavir;   Drug: lamivudine;   Drug: tenofovir
20 Completed A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study
Condition: HIV Infections
Interventions: Drug: Emtricitabine 200mg - Tenofovir 300mg;   Drug: Abacavir 600mg - Lamivudine 300mg

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services